Litigation Details for Boehringer Ingelheim Pharmaceuticals Inc. v. Cadila Healthcare Limited (D. Del. 2019)
✉ Email this page to a colleague
Boehringer Ingelheim Pharmaceuticals Inc. v. Cadila Healthcare Limited (D. Del. 2019)
Docket | ⤷ Sign Up | Date Filed | 2019-07-11 |
Court | District Court, D. Delaware | Date Terminated | 2021-07-27 |
Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | None | Referred To | |
Patents | 10,258,637; 7,579,449; 7,713,938; 8,551,957; 9,949,998 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Boehringer Ingelheim Pharmaceuticals Inc. v. Cadila Healthcare Limited
Details for Boehringer Ingelheim Pharmaceuticals Inc. v. Cadila Healthcare Limited (D. Del. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
0000-00-00 | 4 | Patent/Trademark Report to Commissioner of Patents | ;7,713,938 B2 ;8,551,957 B2 ;9,949,998 B2 ;10,258,637 B2. (lak) (Entered: 07/12/2019) 11 July 2019… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,449 B2 ;… 11 July 2019 1:19-cv-01295 835 Patent - Abbreviated New Drug Application(ANDA) | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |